Crumbl's Copyright Conundrum With Taylor Swift, Beyoncé, Other Artists
Ozempic Causes Blindness, According to New Lawsuit
Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a Maryland man who developed non-arteritic anterior ischemic optic neuropathy after taking the drug for diabetes. While the precise cause of that condition is unknown, the general belief in the medical community is that the condition is caused by insufficient blood supply or ischemia to the optic nerve, the suit alleges.
Writing Strong Antibody Claims: Avoiding or Addressing USPTO Rejections for Written Description and Enablement
Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement rejections under 35 U.S.C. §112(a). The USPTO routinely rejects claims as too broad. The heightened disclosure requirements increase laboratory costs to generate sufficient data for a §112(a)-proof specification.